Cannabis Use in Pregnancy and Downstream effects on maternal and infant health (CUPiD): a protocol for a birth cohort pilot study
Open Access
Abstract
Introduction Cannabis use in pregnancy and post partum is increasing. Accessibility to cannabis has expanded due to the legalisation of cannabis in Canada. Therefore, there is a critical need to monitor the impact of cannabis on pregnancy outcomes and infant neurodevelopment. This pilot study will assess the feasibility of modern recruitment and data collection strategies adapted to the current cannabis environment and inform the design of a multicentre prospective birth cohort. Methods and analysis We will establish a pregnancy and birth cohort of 50 cannabis users and 50 non-users recruited before delivery. We will follow the participants at regular visits from recruitment to 12 weeks post partum. Participants will provide demographic and socioeconomic data, report their cannabis use patterns, and provide biological samples. Biological samples include maternal and infant urine and blood, breastmilk/chestmilk, cord blood, cord tissue, placenta and meconium. All samples will be processed and stored at −80°C until analysis by immunoassay or liquid chromatography-tandem mass spectrometry to determine the presence of cannabis metabolites. In addition, partners will be invited to provide additional socioeconomic and substance use data. Ethics and dissemination Ethics was obtained from Ottawa Health Science Network Research Ethics Board through Clinical Trials Ontario (3791). Our findings will be published in peer-reviewed journals, presented at scientific conferences and shared broadly with patients, healthcare decision-makers, and project partners online and through social media. Trial registration number NCT05309226.Cite NowKeywords
Funding Information
- Canadian Institutes of Health Research (CA3 – 170126)
This publication has 40 references indexed in Scilit:
- Association Between Stillbirth and Illicit Drug Use and Smoking During PregnancyObstetrics & Gynecology, 2014
- Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matricesDrug Testing and Analysis, 2013
- The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 StudyPLOS ONE, 2013
- Birth outcomes associated with cannabis use before and during pregnancyPediatric Research, 2011
- Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R StudyJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboraciónGaceta Sanitaria, 2009
- Maternal Periconceptional Illicit Drug Use and the Risk of Congenital MalformationsEpidemiology, 2009
- Biological Matrices for the Evaluation of In Utero Exposure to Drugs of AbuseTherapeutic Drug Monitoring, 2007
- Bioanalytical procedures for monitoring in utero drug exposureAnalytical and Bioanalytical Chemistry, 2007
- Presence of Δ9-Tetrahydrocannabinol in Human MilkNew England Journal of Medicine, 1982